Yang F, Guo W, Sun S, Huang Y. Combination of Prostate Cancer Antigen 3 (PCA3), Sarcosine, Glypican-1 (GPC1), Urokinase Plasminogen Activator Receptor (uPAR), and Thymidine Kinase 1 (TK1), and T2WI and DWI Radiomics Model for Distinguishing Benign Prostatic Hyperplasia, Prostate Cancer: Prostate Cancer Antigen 3 (PCA3), Sarcosine, Glypican-1 (GPC1), Urokinase Plasminogen Activator Receptor (uPAR), and Thymidine Kinase 1 (TK1), . J Med Biochem [Internet]. 2025 Jul. 7 [cited 2026 Jul. 12];44(6):1376-85. Available from: https://asistent.ceon.rs/index.php/jomb/article/view/57639